Evidence map›Paper›PMID 42056253›Full record

ArticleScientific reports2026

Circulating tumor cell-derived lines exhibit an amoeboid mode of migration.

Guillaume Belthier, Veronika Te Boekhorst, Zeinab Homayed, Jihane Vitre Boubaker, Fanny Grillet, Marie Alexandra Albaret, Momeneh Foroutan, Geneviève De Sousa, Lucile Canterel-Thouennon, Jean-François Bourgaux and 9 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Guillaume Belthier *Institut de Génomique Fonctionnelle, Univ. Montpellier, CNRS, INSERM, Montpellier, France.
Veronika Te Boekhorst *David H. Koch Center for Applied Research of Genitourinary Cancers, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Zeinab HomayedInstitut de Génomique Fonctionnelle, Univ. Montpellier, CNRS, INSERM, Montpellier, France.
Jihane Vitre BoubakerInstitut de Génomique Fonctionnelle, Univ. Montpellier, CNRS, INSERM, Montpellier, France.
Fanny GrilletInstitut de Génomique Fonctionnelle, Univ. Montpellier, CNRS, INSERM, Montpellier, France.
Marie Alexandra AlbaretInserm U1052, UMR5286 Centre de Recherche en Cancérologie de Lyon, CNRS, 69000, Lyon, France.
Momeneh ForoutanPlasticity, Heterogeneity and Tumour Microenvironment, International Research Laboratory - PHANTOM - CNRS and The University of Melbourne, Department of Clinical Pathology, Victorian Comprehensive Cancer Centre, The University of Melbourne, Melbourne, VIC, 3010, Australia.
Geneviève De SousaInserm U1052, UMR5286 Centre de Recherche en Cancérologie de Lyon, CNRS, 69000, Lyon, France.
Lucile Canterel-ThouennonPlateforme MPCC-SIRIC Montpellier Cancer, IRCM, Montpellier, France.
Jean-François BourgauxService d'Hépato-Gastroentérologie, CHU Carémeau, Nîmes, France.
Michel PrudhommeService de Chirurgie Digestive, CHU Carémeau, Nîmes, France.
Emmanuelle SamalinInstitut de Génomique Fonctionnelle, Univ. Montpellier, CNRS, INSERM, Montpellier, France.
Thibault MazardMedical Oncology Department, Institut du Cancer de Montpellier (ICM), University Montpellier, 34298, Montpellier, France.
Gérard LossaintMedical Oncology Department, Institut du Cancer de Montpellier (ICM), University Montpellier, 34298, Montpellier, France.
Lakhdar KhellafInstitut Régional du Cancer de Montpellier (ICM)-Val d'Aurelle, Montpellier, France.
Frédéric HollandePlasticity, Heterogeneity and Tumour Microenvironment, International Research Laboratory - PHANTOM - CNRS and The University of Melbourne, Department of Clinical Pathology, Victorian Comprehensive Cancer Centre, The University of Melbourne, Melbourne, VIC, 3010, Australia.
Hichem C MertaniInserm U1052, UMR5286 Centre de Recherche en Cancérologie de Lyon, CNRS, 69000, Lyon, France.
Peter Friedl *David H. Koch Center for Applied Research of Genitourinary Cancers, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Julie Pannequin *Institut de Génomique Fonctionnelle, Univ. Montpellier, CNRS, INSERM, Montpellier, France. julie.pannequin@igf.cnrs.fr.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Amoeboid migrationCirculating tumor cellsColorectal cancerHuman sectionsMetastasisMouse models

Identifiers

PMID42056253
PMCPMC13315571

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.